002773 康弘藥業
按盤價 
19.150 +0.260 (+1.376%)
19.150 +0.260 (+1.376%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.992 | 14.209 | 13.804 | 7.110 | -5.200 |
| 總資產報酬率 ROA (%) | 10.976 | 12.858 | 12.219 | 6.034 | -4.207 |
| 投入資產回報率 ROIC (%) | 11.931 | 14.057 | 13.516 | 6.877 | -4.430 | 邊際利潤分析 |
| 銷售毛利率 (%) | 89.878 | 88.922 | 88.550 | 90.164 | 89.994 |
| 營業利潤率 (%) | 33.674 | 31.866 | 29.960 | 9.851 | -15.545 |
| 息稅前利潤/營業總收入 (%) | 32.005 | 29.857 | 29.075 | 9.960 | -16.583 |
| 淨利潤/營業總收入 (%) | 28.285 | 26.055 | 25.547 | 11.679 | -8.189 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.605 | 93.231 | 88.628 | 111.772 | 119.577 |
| 價值變動淨收益/利潤總額(%) | 1.663 | 3.582 | 3.694 | 6.717 | -6.562 |
| 營業外收支淨額/利潤總額(%) | -0.927 | -2.200 | 1.449 | 9.721 | 1.391 | 償債能力分析 |
| 流動比率 (X) | 8.434 | 8.107 | 6.097 | 5.542 | 4.044 |
| 速動比率 (X) | 7.884 | 7.490 | 5.620 | 5.099 | 3.799 |
| 資產負債率 (%) | 8.447 | 8.415 | 10.541 | 12.235 | 17.788 |
| 帶息債務/全部投入資本 (%) | -0.136 | -0.149 | -0.179 | -0.232 | -- |
| 股東權益/帶息債務 (%) | -73,472.254 | -66,839.353 | -55,068.346 | -41,848.930 | -17,254.009 |
| 股東權益/負債合計 (%) | 1,083.910 | 1,087.270 | 848.043 | 715.530 | 462.187 |
| 利息保障倍數 (X) | -23.542 | -22.569 | -21.924 | -10.460 | 20.254 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 13.237 | 14.101 | 17.676 | 25.642 | 0.000 |
| 存貨周轉天數 (天) | 315.907 | 301.598 | 290.659 | 271.703 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
